FR2081451B1 - - Google Patents

Info

Publication number
FR2081451B1
FR2081451B1 FR7102233A FR7102233A FR2081451B1 FR 2081451 B1 FR2081451 B1 FR 2081451B1 FR 7102233 A FR7102233 A FR 7102233A FR 7102233 A FR7102233 A FR 7102233A FR 2081451 B1 FR2081451 B1 FR 2081451B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7102233A
Other versions
FR2081451A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of FR2081451A1 publication Critical patent/FR2081451A1/fr
Application granted granted Critical
Publication of FR2081451B1 publication Critical patent/FR2081451B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
FR7102233A 1970-01-23 1971-01-22 Expired FR2081451B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB346470 1970-01-23
GB2190770 1970-05-06
GB2819470 1970-06-10

Publications (2)

Publication Number Publication Date
FR2081451A1 FR2081451A1 (fr) 1971-12-03
FR2081451B1 true FR2081451B1 (fr) 1974-10-18

Family

ID=27254279

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7102233A Expired FR2081451B1 (fr) 1970-01-23 1971-01-22

Country Status (10)

Country Link
US (1) US3769277A (fr)
JP (1) JPS5716115B1 (fr)
AR (1) AR199377A1 (fr)
BE (1) BE761897A (fr)
CA (2) CA945988A (fr)
CH (1) CH580106A5 (fr)
DE (1) DE2103014A1 (fr)
FR (1) FR2081451B1 (fr)
HU (1) HU162408B (fr)
NL (1) NL7100861A (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994884A (en) * 1970-01-23 1976-11-30 Glaxo Laboratories Limited 3-Vinyl-7β-(2,2-disubstituted acetamido)-cephalosporins
GB1361183A (en) * 1970-08-06 1974-07-24 Glaxo Lab Ltd Cephalosporin compounds
GB1360972A (en) * 1970-08-06 1974-07-24 Glaxo Lab Ltd Cephalosporin compounds
US4065620A (en) * 1971-06-14 1977-12-27 Eli Lilly And Company 3-(Substituted) vinyl cephalosporins
BE789817A (fr) * 1971-10-07 1973-04-06 Glaxo Lab Ltd Perfectionnements aux composes de cephalosporine
US4016158A (en) * 1971-12-31 1977-04-05 Roussel-Uclaf Cephalosporin derivatives
BE791160A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Nouveaux cephemes substitues
SE428022B (sv) * 1972-06-29 1983-05-30 Ciba Geigy Ag 7beta-amino-cefam-3-on-4-karboxylsyraforeningar till anvendning for framstellning av cefalosporinderivat
CA1022542A (en) * 1973-01-09 1977-12-13 Bruno Fechtig Process for the manufacture of methylene compounds
US3974151A (en) * 1973-06-05 1976-08-10 Merck & Co., Inc. Cephalosporin compounds
US4039535A (en) * 1973-12-10 1977-08-02 Eli Lilly And Company 7-[α-(GUANYL-1-UREIDO)PHENYLACETAMIDO]-3-SUBSTITUTED CEPHALOSPORIN ANTIBIOTICS
US4095021A (en) * 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US3919209A (en) * 1974-01-16 1975-11-11 Lilly Co Eli 2,3-Methylenecepham antibiotics
GB1505345A (en) * 1974-04-10 1978-03-30 Beecham Group Ltd Cephalosporins
JPS5129492A (en) * 1974-09-04 1976-03-12 Sankyo Co Sefuarosuhorinjudotai no seiho
US4108992A (en) * 1975-05-10 1978-08-22 Beecham Group Limited Cephalosporin analogues and compositions
US4101658A (en) * 1975-06-04 1978-07-18 Shionogi & Co., Ltd. Antibacterial hydrazono cephalosporins
US3983113A (en) * 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
US4049806A (en) * 1975-08-15 1977-09-20 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
JPS5253890A (en) * 1975-10-14 1977-04-30 Syntex Inc Production of cephalosporin type compound
CA1085392A (fr) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporines
US4089956A (en) * 1976-09-08 1978-05-16 Smithkline Corporation 7-Acylamino-8-oxo-3-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives and bactericidal compositions and use thereof
US4112087A (en) * 1976-11-04 1978-09-05 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials having a substituted propenyl group in the 3-position
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
US4390693A (en) * 1977-07-27 1983-06-28 Merck & Co., Inc. Cephalosporin compounds
US4291031A (en) * 1979-02-19 1981-09-22 Fujisawa Pharmaceutical Co., Ltd. 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same
FR2457297A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
FR2494275A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2494280A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
FR2494276A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
US4546101A (en) * 1982-09-10 1985-10-08 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds useful for treating infectious diseases in human being and animals and processes for preparation thereof
ZA84584B (en) * 1983-01-28 1984-09-26 Bristol Myers Co Substituted vinyl cephalosporins
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
FR2570702B1 (fr) * 1984-09-27 1987-01-09 Sanofi Sa Derives des cephalosporines, procedes d'obtention et leur application a titre d'antibiotiques
FR2580652B1 (fr) * 1985-04-22 1989-01-06 Bristol Myers Co Acide 7-amino-3-propenylcephalosporanique et ses esters
US4699979A (en) * 1985-04-22 1987-10-13 Bristol-Meyers Company 7-amino-3-propenylcephalosporanic acid and esters thereof
JPS636520U (fr) * 1986-06-25 1988-01-16
US4847373A (en) * 1987-02-26 1989-07-11 Bristol-Myers Company Production of 3-allyl- and 3-butenyl-3-cephems
DE3734004A1 (de) * 1987-05-26 1988-12-15 Bayer Ag Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3734005A1 (de) * 1987-05-26 1988-12-15 Bayer Ag Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69231815T2 (de) 1991-03-08 2001-09-27 Biochemie Gmbh Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
US6248881B1 (en) 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
WO1993016084A1 (fr) * 1992-02-05 1993-08-19 Biochemie Gesellschaft M.B.H. Procede de purification d'un derive d'acide 3-cephem-4-carboxylique
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
US7196027B2 (en) * 2000-06-05 2007-03-27 Kabushiki Kaisha Ohara Optical glass suffering little change in refractive index by radiation of light

Also Published As

Publication number Publication date
CA945988A (en) 1974-04-23
AR199377A1 (es) 1974-08-30
NL7100861A (fr) 1971-07-27
US3769277A (en) 1973-10-30
CA954128A (en) 1974-09-03
BE761897A (fr) 1971-07-22
JPS5716115B1 (fr) 1982-04-02
HU162408B (fr) 1973-02-28
CH580106A5 (fr) 1976-09-30
FR2081451A1 (fr) 1971-12-03
DE2103014A1 (de) 1971-07-29

Similar Documents

Publication Publication Date Title
AU1146470A (fr)
AU2044470A (fr)
AU1473870A (fr)
AU2130570A (fr)
AU1326870A (fr)
AU1336970A (fr)
AU2017870A (fr)
AU2085370A (fr)
AU1517670A (fr)
AU1833270A (fr)
AU1716970A (fr)
BE771411A (fr)
AU1603270A (fr)
AU1689770A (fr)
AU2131570A (fr)
AU2144270A (fr)
AU1086670A (fr)
AU1832970A (fr)
AU1189670A (fr)
AU2119370A (fr)
AU1841070A (fr)
AU1789870A (fr)
AU2115870A (fr)
AU1974970A (fr)
AU1943370A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse